Breast Surgery Prehab Platform Centers Patient Voice Throughout Product Development and Post- Market Decision-Making
Plexāā developed a digital prehabilitation platform (BLOOM⁴³) to support individuals preparing for and recovering from breast surgery, with development driven by gaps in accessible, evidence-based patient guidance. Patient perspectives were integrated continuously across design and development through direct input on content, usability, and messaging to ensure the platform reflects lived experiences and supports patient needs.
Quick Facts Organization name: BLOOM⁴³ |
Product Type(s)
medical device:
- home-use device
digital health technology:
- health and wellness
- care support
Product Medical Specialty Area(s)
- general and plastic surgery
Stakeholders
- medtech company: internal discovery/research and development (R&D) teams
- medtech company: internal clinical affairs/R&D teams
- medtech company: internal regulatory affairs teams
- medtech company: internal market access teams
- medtech company: internal medical affairs teams
- medtech company: internal marketing teams
- medtech company: internal compliance teams
- patients and caregivers, patient organizations
Methods and Sources of Patient Input
- patient advisory boards
- patient advocacy organizations
- interviews/focus groups/surveys
- patient journey mapping
- public comment/testimony
- advisory committee participation (including Data and Safety Monitoring Board)
- human-centered design methodologies
- patient-generated health data
- patient-developed solutions
- patient-centered outcomes research
- patient-driven research agendas and investments
- patient-sensitive design controls
- real-world data/evidence
- consumer data (health and other)
- customer satisfaction data
- social media/online listening
Purpose of Patient Engagement
The heart of Plexāā and BLOOM⁴³ is the patient voice and their lived experiences, with a clear focus on addressing unmet needs identified by the patient community. The founder, a plastic surgeon, wanted to address the significant gap in accessible, evidence-based guidance to support patients in optimizing their preparation and recovery. The development of the BLOOM⁴³ app was therefore driven by the goal of providing structured, trustworthy, and patient-centered information to empower individuals undergoing breast surgery.
Description of Patient Engagement Activities
Patient advocates have contributed to the development of both the device and the app, ensuring that the patient perspective is embedded at every stage. This has included providing insight into lived experience; reviewing content; shaping messaging; and advocating for clarity, accessibility, and emotional sensitivity in how information is delivered. Patient input has been gathered through direct conversations, structured feedback on app content and user experience, and ongoing dialogue throughout product development.
Engagement has also been continuous and iterative, allowing patient insight to meaningfully influence design decisions and refinements over time. This model has since been expanded internationally.
Impact of Patient Engagement
Patient engagement has had a measurable, meaningful impact across the company, patient community, and wider stakeholder community. From a patient perspective, 100 percent of app users surveyed reported feeling more empowered in preparing for surgery. Engagement metrics further reinforce this impact. The app has been downloaded over 1,000 times across over 50 countries, with sustained weekly engagement averaging approximately one hour and 20 minutes per user. This depth of engagement suggests that patients are actively using and valuing the content as part of their preparation journey.
Clinical outcomes have also been encouraging. Among patients using the device as part of their preparation protocol, there have been zero reported postsurgical complications within the monitored cohort, supporting the potential effectiveness of the intervention.
From a company and partner perspective, patient engagement has strengthened credibility, usability, and adoption. The app has achieved a Net Promoter Score of 86, indicating exceptionally high user satisfaction and likelihood to recommend.
These results provide strong validation for investors, clinicians, and research partners that embedding the patient voice into product development leads to solutions that are trusted, relevant, and impactful.
Lessons Learned
This patient engagement effort highlights the importance of authentic and early patient involvement in R&D.
- Engaging patients from the outset ensures that innovation is grounded in real-world experiences and aligned with genuine unmet needs rather than assumptions about what patients may require.
- Embedding patient champions within the organization has also proven invaluable.
- Having lived-experience insights represented internally enables continuous patient-centered decision-making, strengthens the relevance and clarity of product development, and ensures that empathy remains central to innovation.
- Ultimately, building with patients, not just for patients, enhances validation of need, improves usability and adoption, and increases the likelihood that solutions will deliver a meaningful clinical and emotional impact.